BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 12461687)

  • 1. Delineation of an estimated 6.7 MB candidate interval for an anophthalmia gene at 3q26.33-q28 and description of the syndrome associated with visible chromosome deletions of this region.
    Male A; Davies A; Bergbaum A; Keeling J; FitzPatrick D; Mackie Ogilvie C; Berg J
    Eur J Hum Genet; 2002 Dec; 10(12):807-12. PubMed ID: 12461687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal diagnosis of primary anophthalmia with a 3q27 interstitial deletion involving SOX2.
    Guichet A; Triau S; Lépinard C; Esculapavit C; Biquard F; Descamps P; Encha-Razavi F; Bonneau D
    Prenat Diagn; 2004 Oct; 24(10):828-32. PubMed ID: 15503273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic heterogeneity of syndromic X-linked recessive microphthalmia-anophthalmia: is Lenz microphthalmia a single disorder?
    Ng D; Hadley DW; Tifft CJ; Biesecker LG
    Am J Med Genet; 2002 Jul; 110(4):308-14. PubMed ID: 12116202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOX2 anophthalmia syndrome: 12 new cases demonstrating broader phenotype and high frequency of large gene deletions.
    Bakrania P; Robinson DO; Bunyan DJ; Salt A; Martin A; Crolla JA; Wyatt A; Fielder A; Ainsworth J; Moore A; Read S; Uddin J; Laws D; Pascuel-Salcedo D; Ayuso C; Allen L; Collin JR; Ragge NK
    Br J Ophthalmol; 2007 Nov; 91(11):1471-6. PubMed ID: 17522144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Del(14)(q22.1q23.2) in a patient with anophthalmia and pituitary hypoplasia.
    Lemyre E; Lemieux N; Décarie JC; Lambert M
    Am J Med Genet; 1998 May; 77(2):162-5. PubMed ID: 9605291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular cytogenetic characterization of a subtle interstitial del(3)(p25.3p26.2) in a patient with deletion 3p syndrome.
    Cargile CB; Goh DL; Goodman BK; Chen XN; Korenberg JR; Semenza GL; Thomas GH
    Am J Med Genet; 2002 Apr; 109(2):133-8. PubMed ID: 11977162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescence in situ hybridization studies using BAC clones of the EVI1 locus in hematological malignancies with 3q rearrangements.
    Madrigal I; Carrió A; Gómez C; Rozman M; Esteve J; Nomdedeu B; Campo E; Costa D
    Cancer Genet Cytogenet; 2006 Oct; 170(2):115-20. PubMed ID: 17011981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further delineation of 9q22 deletion syndrome associated with basal cell nevus (Gorlin) syndrome: report of two cases and review of the literature.
    Yamamoto K; Yoshihashi H; Furuya N; Adachi M; Ito S; Tanaka Y; Masuno M; Chiyo H; Kurosawa K
    Congenit Anom (Kyoto); 2009 Mar; 49(1):8-14. PubMed ID: 19243411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cytogenetic characterization of terminal 14q32 deletions in two children with an abnormal phenotype and corpus callosum hypoplasia.
    Schneider A; Benzacken B; Guichet A; Verloes A; Bonneau D; Collot N; Dastot-Le-Moal F; Goossens M; Taine L; Landais E; Gaillard D; Doco-Fenzy M
    Eur J Hum Genet; 2008 Jun; 16(6):680-7. PubMed ID: 18197200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duplication 3q syndrome: molecular delineation of the critical region.
    Aqua MS; Rizzu P; Lindsay EA; Shaffer LG; Zackai EH; Overhauser J; Baldini A
    Am J Med Genet; 1995 Jan; 55(1):33-7. PubMed ID: 7702094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Newborn infant with inherited ring and de novo interstitial deletion on homologous chromosome 22s.
    Wenger SL; Boone LY; Cummins JH; Del Vecchio MA; Bay CA; Hummel M; Mowery-Rushton PA
    Am J Med Genet; 2000 Apr; 91(5):351-4. PubMed ID: 10766997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection and delineation of an unusual 17p11.2 deletion by array-CGH and refinement of the Smith-Magenis syndrome minimum deletion to approximately 650 kb.
    Schoumans J; Staaf J; Jönsson G; Rantala J; Zimmer KS; Borg A; Nordenskjöld M; Anderlid BM
    Eur J Med Genet; 2005; 48(3):290-300. PubMed ID: 16179224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel heterozygous OTX2 mutations and whole gene deletions in anophthalmia, microphthalmia and coloboma.
    Wyatt A; Bakrania P; Bunyan DJ; Osborne RJ; Crolla JA; Salt A; Ayuso C; Newbury-Ecob R; Abou-Rayyah Y; Collin JR; Robinson D; Ragge N
    Hum Mutat; 2008 Nov; 29(11):E278-83. PubMed ID: 18781617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel mutations in BCOR in three patients with oculo-facio-cardio-dental syndrome, but none in Lenz microphthalmia syndrome.
    Horn D; Chyrek M; Kleier S; Lüttgen S; Bolz H; Hinkel GK; Korenke GC; Riess A; Schell-Apacik C; Tinschert S; Wieczorek D; Gillessen-Kaesbach G; Kutsche K
    Eur J Hum Genet; 2005 May; 13(5):563-9. PubMed ID: 15770227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An integrated physical and gene map of the 3.5-Mb chromosome 3p21.3 (AP20) region implicated in major human epithelial malignancies.
    Protopopov A; Kashuba V; Zabarovska VI; Muravenko OV; Lerman MI; Klein G; Zabarovsky ER
    Cancer Res; 2003 Jan; 63(2):404-12. PubMed ID: 12543795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion 2q37.3 and autism: molecular cytogenetic mapping of the candidate region for autistic disorder.
    Lukusa T; Vermeesch JR; Holvoet M; Fryns JP; Devriendt K
    Genet Couns; 2004; 15(3):293-301. PubMed ID: 15517821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion at 14q22-23 indicates a contiguous gene syndrome comprising anophthalmia, pituitary hypoplasia, and ear anomalies.
    Nolen LD; Amor D; Haywood A; St Heaps L; Willcock C; Mihelec M; Tam P; Billson F; Grigg J; Peters G; Jamieson RV
    Am J Med Genet A; 2006 Aug; 140(16):1711-8. PubMed ID: 16835935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletions of 20p12 in Alagille syndrome: frequency and molecular characterization.
    Krantz ID; Rand EB; Genin A; Hunt P; Jones M; Louis AA; Graham JM; Bhatt S; Piccoli DA; Spinner NB
    Am J Med Genet; 1997 May; 70(1):80-6. PubMed ID: 9129746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distal del(4) (q33) syndrome: detailed clinical presentation and molecular description with array-CGH.
    Kitsiou-Tzeli S; Sismani C; Koumbaris G; Ioannides M; Kanavakis E; Kolialexi A; Mavrou A; Touliatou V; Patsalis PC
    Eur J Med Genet; 2008; 51(1):61-7. PubMed ID: 17998173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polycystic kidneys and del (4)(q21.1q21.3): further delineation of a distinct phenotype.
    Velinov M; Kupferman J; Gu H; Macera MJ; Babu A; Jenkins EC; Kupchik G
    Eur J Med Genet; 2005; 48(1):51-5. PubMed ID: 15953406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.